https://www.avient.com/sites/default/files/2020-10/case-study-one-pager-trilliant-xr-xray-glasses.pdf
M E D I C A L E Q U I P M E N T
M A N U FA C T U R E R
S U R G I C A L X - R A Y G L A S S E S
• Replace lead while providing uniform shielding
performance
• Radiation shielding up to 140KeV
• Improve glasses design
• Compliance with Radiation Protection Regulation: Adult
eye exposure must be below 20 mSv per calendar year
• Conducted extensive testing to ensure comparable and
uniform shielding performance
• Improved geometric flexibility
• Lowered shielding component costs 30-50% by
eliminating machining and assembly steps (associated
with lead)
• Reduced weight of the glasses and enabled a more
ergonomic design
• Eliminated disposal concerns associated with lead
Trilliant™ XR Lead Replacement
Thermoplastics
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2022-07/Additives and Colorants for PP-R PP-RCT Pipes - Application Snapshot.pdf
P I P E & F I T T I N G S
M A N U FAC T U R E R
W A T E R / F L U I D D I S T R I B U T I O N
• Suitable for PP-R and PP-RCT
• Specific color targets for external and inner layers
• Improved resistance to chlorine for the inner layer
• Food contact approval for the inner layer
• Batch-to-batch consistency
• Matched color references in concentrates
suitable for PP-R and PP-RCT
• Developed custom colorant/antioxidant
combination masterbatch with high
resistance to chlorine and food contact
approval for the inner layer
• Ensured batch-to-batch consistency for
sustained performance
Color concentrates and color/antioxidant
combination masterbatch
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2020-07/case-study-one-pager-versalloy-infusion-adapter-port.pdf
M E D I C A L E Q U I P M E N T
M A N U FA C T U R E R
C L O S E D S Y S T E M D R U G
T R A N S F E R D E V I C E
• A new material for a seal inside the next generation of
closed system drug transfer device
• Compliance with stringent regulatory standards:
• Biocompatibility to ISO10993
• USP VI compliance
• Provided regulatory support services and
expertise throughout extensive medical
approval process
• Provided a custom formulation compliant with
the highest healthcare regulatory standards
• Enabled material to be manufactured and
shipped globally
Custom Versalloy™ HC 9220-90 Formulation
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2021-07/fiber-line-global-product-selection-guide.pdf
FIBER-LINE™
High Performance
Synthetic Fibers
PRODUCT SELECTION GUIDE
FIBER-LINE™ HIGH PERFORMANCE SYNTHETIC FIBERS
Kevlar® Para-Aramid
Nomex®
Meta-Aramid
Vectran® LCP Zylon® PBO
Carbon
Fiber
UHMWPE PET Polyester Fiberglass Novoloid
Technora®
Filament Yarn
TECHNICAL PROPERTIES Standard Modulus
High
Modulus
Standard
Modulus
Standard
Modulus
High
Modulus
Standard
Modulus
High
Modulus
Standard
Modulus
Standard
Modulus
High
Modulus
High
Tenacity
Low
Shrink
E-Glass S-Glass
Standard
Modulus
Standard
Modulus
Breaking Tenacity (g/d) 23.0 23.6 5.0 23.0 30.0 42.0 42.0 23.0 28.0 38 9.3 8.4 6.0 - 7.3 6.7 - 9.4 1.5 28.0
Specific Gravity (Ratio) 1.44 1.44 1.38 1.40 1.40 1.54 1.56 1.80 0.97 0.97 1.38 1.38 2.58 2.48 1.27 1.39
Elongation at Break (%) 3.5 2.5 30.0 3.8 2.8 3.5 2.5 1.5 3.5 3.1 14.6 19.5 3.5 5.5 30.0 - 40.0 4.6
Tensile Modulus (g/d) 555 885 125 600 830 1200 1800 1480 850 1250 120 70 200–275 140–170 2.5–5.0 590
Equilibrium Moisture Regain
at 55% RH (%)
5.0 5.0 4.5
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Welcome%2520and%2520Introduction.pdf
Hanna
consolidate
• Cultures clash –
commodity wins
• Dependent on
income derived from
commodity joint
ventures
The First 6 Years
• Globally organized along
three strategic platforms
• Non-core equity
investment dispositions
• Talent upgrades, discipline
instilled throughout
organization
• New CEO hired to
transform POL into
specialty business
�18 of 20 officers new
• Implemented four
pillar strategy
• Nearly 50% of
The Second 6 Years
History of PolyOne – A Transformation
• Focused on increasing
volume, not profits
• Heavily tied to cyclical
markets
2000 2006 2012
The FormationThe Formation
The TransformationThe Transformation
The New PolyOneThe New PolyOne
organization
• Demonstrated ability
to deliver
• Nearly 50% of
business operating
income derived from
Specialty Platform*
• Specialty assets
acquired
*Pro forma for ColorMatrix acquisition
Page 8
30%
50%
70%
90%
$10
$12
$14
$16
$18
PolyOnePolyOne
Stock Price
S&P 500 (relative performance)
Strategy and Execution Drive Results
| | | |
-50%
-30%
-10%
10%
30%
$0
$2
$4
$6
$8
$10
2006 2007 2008 2009 2010 2011 2012
Page 9
Four Pillar Strategy
The World’s Premier Provider of Specialized
Polymer Materials, Services & Solutions
Page 10
60%
80%
100%
%
o
f
O
p
e
ra
ti
n
g
I
n
co
m
e
*
Old
PolyOne
Transformation
2012
Target
“What We Said”
Mix Shift Highlights Specialty Transformation
Ahead of Schedule
*Operating Income excludes Corporate Charges
** Pro Forma for the acquisition of ColorMatrix and divestiture of SunBelt
2%
34%
42%
50% >50%
0%
20%
40%
2005 2008 2011 2011** 2012
%
o
f
O
p
e
ra
ti
n
g
I
n
co
m
e
*
JV's PP&S Distribution Specialty
Specialty OI $5M $46M $89M $117M “What We Said”
Page 11
2007 2012 Target 2011
“Where we were” “What we said” “Where we are”
1) Operating Income %
Specialty 3.2% 10% - 12% 8.9%
PP&S 6.1% 8% - 10% 7.2%
Pro forma ColorMatrix
Proof of Performance
Distribution 3.0% 4% - 5% 5.6%
2) Specialty Platform
sss% of Operating Income
20% >50% 50%
3) Specialty Vitality
Index
21% 35% - 40% 49%
4) ROIC* (pre-tax) 11% >15% 16%
5) Sales outside the US 37% >40% 40%
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 12
2011
Pro forma ColorMatrix
2015 Target
“Where we are” “Where we expect to be”
1) Operating Income %
Specialty 8.9%
PP&S 7.2%
12 – 16%
9 – 12%
Elevating our Expectations and Yours
PP&S 7.2%
Distribution 5.6%
2) Specialty Platform
% of Operating Income
50%
3) ROIC* (after-tax) 10%
4) Adjusted Annual
EPS Growth
3 yr CAGR = 71%
9 – 12%
6 – 7.5%
65 – 75%
15%
Double Digit Expansion
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 13
• Four pillar strategy, coupled with our ability to
execute is driving results
• Strong leadership team driving growth & executing
• Innovation and services provide differentiation and
How do we get there?
https://www.avient.com/sites/default/files/2021-10/remafin-ep-white-masterbatches-for-pharma-application-bulletin_0.pdf
KEY CHARACTERISTICS
• Manufactured under change control principles
beyond CAS number (similar level as MEVOPUR
concentrates), reducing risk of change
• Free from animal-derived substances and
phthalates
• Suitable for blown film, injection molding,
blow molding and extrusion
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1
- USP chapters , including Class VI,
a requirement for ophthalmic and nasal drugs
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
- USP and USP light transmission
• Registered Drug Master File (Type III)
• Food contact compliance established with
FDA/EU*
APPLICATION BULLETIN
CARRIER
MATERIAL
PIGMENT
CONTENT/TYPE
LIGHT
FASTNESS
THERMAL
STABILITY
PRODUCT
CODE
HDPE 50% TiO2 8 300°C PH00075525
LLDPE 60% TiO2 8 300°C PL00075542
LLDPE 70% TiO2 8 300°C PL00075545
PP 50% TiO2 8 300°C PP00075717
Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2020-12/case-study-versaflex-ce-clear-phone-case-1.pdf
PHONE CASE
BRAND
C L E A R P H O N E C A S E S
• Optically clear
• Non-yellowing
• Good stain resistance
• Bondable to PC
• Formulated a custom solution to enhance stain
resistance and tensile strength
• Collaborated on application and technical
services to help ensure end product maintained
optical clarity when texture was added
• Provided manufacturing support to reduce scrap
• Coordinated across multiple regions for supply
continuity and technical support to serve
customer’s global needs
Versaflex™ CE 3320-80 TPE
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2022-05/BIO additives MR snapshot 2022 Final.pdf
BIO additives MR snapshot 2022 Final
EXTRUSION CAST
PROCESSOR
T H I N P L A F I L M & B A G S
• Non-stick performance during manufacturing
• Excellent film quality with good aesthetics
• Efficient and clean process performance
• Compliant with food contact applications*
• Provided a performance additive to prevent
biodegradable resin from sticking to the
chill-roll surface
• Reduced the polymer friction factor on metal
surfaces, resulting in a better film quality
• Helped improve the manufacturing process
with fewer cleaning steps
CESA™ OnCap™ & BIO Additives
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2020-12/excelite-1-page-case-study-putty-knife_0.pdf
Excelite OnePager Putty Knife
PUTTY KNIFE
MANUFACTURER
N O R T H A M E R I C A
• Reduce current scrap rate of 30%
• Eliminate prominent sink marks
• Minimize random short shots
• Reduced scrap rate to 1%
• Eliminated sink marks
• Improved mold fill
• Improvement in cell structure increased cell
density and dimensional stability during critical
cooling time
Excelite™ IM Chemical Foaming Additives
KEY REQUIREMENTS*
WHY AVIENT?
https://www.avient.com/sites/default/files/2023-11/OnFlex S KE Power Tool - case study snapshot.pdf
GLOBAL
APPLIANCE BRAND
P O W E R T O O L H A N D L E
• Bonding to ABS
• Scratch resistance
• Colorable compound
• Easy to grip/soft touch
• Worked in synergy across business to
produce a scratch resistant material
suitable for ABS bonding in 19 different
color options
• Made new ergonomic design possible
through better material properties,
especially grip and soft touch
• Enabled customer to market next
generation of power tool, with updated
look and feel
OnFlex™ S KE Series
KEY REQUIREMENTS
WHY AVIENT?